How can someone save lives with #ArtificialIntelligence and #physics? #Startup Ebenbuild can just do it! „Our aim is to shorten and improve the patients' treatment with multi-modal data for precise predictions and fine-tuned adjustments.“ That is the consens of the founders Dr. Kei Wieland Müller, Prof. Wolfgang A. Wall, Dr. Jonas Biehler and Dr. Karl-Robert Wichmann, to avoid⚡damage from 🫁 #artificalrespiration, that require 400,000 people alone in Germany! #Ebenbuild developed a proprietary software that uses computer tomography images and #AI to create a virtual, patient-specific model of the lung - a digital lung twin. With this #advancedtechnology they want to find the best ventilation method for patients in a personalized and precise manner. Discover how this technology can also improve #drugresearch, what they see as the key to success and their future (🇺🇸 US) plans in the📘#startupstory of our current biotechreport "BIOTECH IN BAVARIA -INCUBATING SCIENCE FOR HEALTH": ➡️ https://lnkd.in/eftaj5aD #digitallung #Acuterespiratorystresssyndrome #ARDS #respiratorycomplication #intensivecare #ICU #Covid19 #personalizedmedicine #Biotechreport #InnovationinBavaria
BioM Biotech Cluster Development GmbH
Biotechnologieforschung
Martinsried, Bavaria 9.195 Follower:innen
Management organisation for the Bavarian biotechnology - We accelerate medical innovation
Info
Cluster Management by BioM: Since 1997, Munich’s biotech sector has been supported by BioM Biotech Cluster Development GmbH, a not-for profit service company located in Martinsried in the Southwest of Munich. BioM is sponsored by the Bavarian State Ministry of Economic Affairs and has been commissioned with several tasks and projects which aim to foster Bavaria’s biotechnology sector. BioM offers several services, in particular for small and medium-sized biotech enterprises to help accelerating biomedical innovation. BioM is awarded "Gold Label of Cluster Excellence".
- Website
-
http://www.bio-m.org
Externer Link zu BioM Biotech Cluster Development GmbH
- Branche
- Biotechnologieforschung
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Martinsried, Bavaria
- Art
- Einzelunternehmen (Gewerbe, Freiberufler etc.)
- Gegründet
- 1997
Orte
-
Am Klopferspitz 19a
Martinsried, Bavaria 82152, DE
Beschäftigte von BioM Biotech Cluster Development GmbH
-
Andreas Berghammer
Head of Strategic Management bei BioM Biotech Cluster Development GmbH
-
madhura khare
laboratory assistant at bioM
-
Petra Burgstaller
Supporting Life Sciences Ventures | Incubation & MAxL Co-Lead at BioM Biotech Cluster Development GmbH
-
Christina Enke-Stolle
Incubation & MAxL Co-Lead, Partnership Management, Munich Accelerator Life Sciences & Medicine
Updates
-
👨🔬 👩🔬 Are you a #startup or university-based project pioneering the future of #therapeutics and #vaccines? Then join the VITAL – A BARDA BAN Hub Biotech Accelerator & Funding Award Programs! ➡ https://lnkd.in/dmBXHXvY BARDA is looking for innovative solutions that align with its mission to enhance #pandemic preparedness and #health security. You can: ✅ participate in a specially designed Biotech Accelerator ✅ receive non-dilutive funding in the amount of USD 50k to USD 200k. 📅 Application deadline: August 23, 2024. VITAL is led by Start2 Group in collaboration with partners Advise Connect Inspire, LLC (ACI) and BioLabs. On the one hand, there is the opportunity to participate in a specially designed Biotech Accelerator and additionally receive non-dilutive funding in the amount of USD 50k to USD 200k.
-
❗ Letzte Chance: Frühbucherpreis nur noch bis zum 12. August❗ Sie arbeiten in einem #Biotech- oder #Pharma-Unternehmen und möchten tiefer in die Themen #Zelltherapie/ #Gentherapie, Genetische Modifikation und #CRISPRCas bei „Advanced Therapies“, Immunologie, „From Hit to Drug to Market“ sowie Molekulare Diagnostik & #KI-gestützte Medikamentenentwicklung eintauchen? Ihre Kunden oder Klienten kommen aus dem Biotech-Umfeld? Dann ist dieser maßgeschneiderte #BioM Crashkurs Biotechnologie für Fachfremde genau das Richtige für Sie! An sieben Seminarabenden vermitteln wir Ihnen leicht verständlich die Grundlagen und aktuellen wissenschaftlichen Ansätze auf dem Gebiet der pharmazeutischen Biotechnologie. 👩🏫 BioM Crashkurs #Biotechnologie, einem #Intensivkurs für Nicht-Biotechnologen 🕕 Was? 7 Kursabende, immer donnerstags 🗓️ Wann? 12. September – 07. November 2024, jeweils 17:15 – 19:45 Uhr 📍 Wo? #BioM, Am Klopferspitz 19a, 82152 Martinsried/München Programm & Anmeldung: ➡️ https://lnkd.in/ewaWxHWQ Lernen Sie jetzt von diesen Profis, den Experten aus den Bereichen Biotechnologie, #Diagnostik, #Therapie und #Regulierung sowie #Arzneimittelentwicklung: 👉 Prof. Dr. Ralf Huss, BioM Biotech Cluster Development GmbH 👉 Prof. Dr. Philipp Korber, Biomedical Center Munich, Ludwig-Maximilians-Universität München 👉 Prof. Dr. Wolfgang Wurst, Helmholtz Munich 👉 Prof. Dr. Uwe Jacob, #WestendInnovation 👉 Dr. Samson Fung, #FungConsulting 👉 Prof. Dr. Andreas Jung, Ludwig-Maximilians-Universität München, Medizinische Fakultät Der Kurs ist für Studierende, Absolventen und Berufstätige im Bereich der (akademischen) #Biowissenschaften, Pharma- und Biotech-Industrie und interessierte Nicht-Biotechnologen! #Weiterbildung #Fortbildung #Pharmazie #Drugdevelopment #LifeSciences #Akademie #Forschung
-
„Climate change is a driving force behind #allergies.“ #Climatechange is altering our weather and therefore our living conditions. Higher temperatures, longer pollen counts and new pathogens are spreading in our latitudes due to changing environmental conditions. What effects does climate change have on our #health and what measures - including preventive measures - do we need? We placed these questions with Prof. Claudia Traidl-Hoffmann, Professor of Environmental Medicine at the Universität Augsburg and Director of the Institute of #EnvironmentalMedicine at Helmholtz Munich. In our interview, she talks about health consequences, new #pathogens and why every transition (energy, urban planning, #healthcare) needs to be seen as a #healthproject: ➡️https://lnkd.in/evZ2kY9s #biotechreport #allergology #allergies #humanenviromentinteraction #climatechangeeffects #preventiveaction #biotechreport #InnovationinBavaria
-
The Bavarian 💊 biopharmaceutical industry 💊 continues to show impressive growth and stability despite global economic challenges. In 2023, the number of biotech and #pharmaceutical companies in Bavaria, including #CROs and other companies showed stable development and employment at a new high 📈. With over 500 companies, 58,000 employees, just under a dozen new #startups and a #financing total of over 470 million euros, #Bavaria and #Munich remains one of the hotspots of #biotechnology innovation in 🇪🇺 #Europe. Find sector key figures, foundations, mergers & acquisitions and investments as well as the current drug pipeline by phase and indication in the #BioM #biotechreport 2023/24 “BIOTECH IN BAVARIA - INCUBATING SCIENCE FOR HEALTH”: ➡️ https://lnkd.in/eKE9UGrA #Biopharma #Biotech #Pharma #LifeSciences #BiotechHub #StartupEcosystem #BiotechCluster #Clusterdevelopment #InnovationinBavaria
-
🚀 leon-nanodrugs secures financing to expand its portfolio! 🚀 The #Martinsried-based company develops and commercializes its innovative technology for the #encapsulation of genetic material and other active ingredients in nano drug carriers such as lipid nanoparticles (#LNPs). ➡ https://lnkd.in/dR_dbbCa 👏 Congratulations Christian Nafe and team! With its technology, the company aims to make modern drugs such as prophylactic #mRNA vaccines as well as individual therapies such as personalized cancer vaccines available to patients quickly and on a large scale. New lead investor LBBW Venture Capital GmbH closed the round together with new investors and existing shareholders like Albany Private Equity Holdings Pty Ltd., @CD-Venture GmbH, Eckenstein-Geigy Stiftung, Signet Healthcare Partners, TVM Capital Life Science, and others. IZB - Innovation and Start-up Center Biotechnology
-
Where do #jobseekers in Munich and Bavaria watch out for jobs in #biotechnology, #pharma, and #medtech? Where do Bavarian #biotech #companies present themselves to attract the future skilled workers and specialists? At… 🥁 🥁 … the "Biotech & Pharma Career Day 2024" ! This #Munich career orientation event brings together the next-generation of doctoral, postdoctoral and medical researchers with biotech companies in the greater Munich area. 🗓️ When? This year on 1st October 2024, 9 am - 4 pm 📍 Where? At the Biomedical Center Munich (BMC) LMU, Großhaderner Str. 9, 82152 Martinsried (on-site) If you are a #SME, rising #startup oder expanding company, this is your chance to get in contact with the bright minds in #lifesciences, #biotechnology and #medicine that will contribute to your company’s success! There are only a few places for companies left to participate at the 👉 Exhibition with networking in the auditorium 👉 Company presentations as small lectures Apply as a participating company and find all the information you need about exhibiting at: ➡️ https://lnkd.in/en3QytRs Or get contact with Dr. Christoph E. oder Dr. Max Pöhlmann for details! Already confirmed companies: Alira Health | FGK Clinical Research GmbH | Eurofins RBLSC BioPharma Product Testing Munich GmbH | ITM Isotope Technologies Munich SE | ibidi GmbH | MLL Münchner Leukämielabor | MSD | PHIO scientific GmbH | PSI CRO AG | Sandoz in Deutschland #muenchenjobs, #pharmajobs, #biotechjobs #medicaljobs #chemicaljobs #recruiting #academia #humanresources #jobmarket
-
What is going on in #BavarianBiotechnology? How has it developed over the past year? What are the topics that move the players in #Bigpharma, SMEs, academia, #LifeSciences and #Venturecapital? Who has founded, who has merged, who has taken big steps in the development of new #therapeutics, #therapies, (digital) platform #technologies and financing? The latest biotech report 📘„BIOTECH IN BAVARIA – INCUBATING SCIENCE FOR HEALTH“ gives you the answers and insights! ➡️ https://lnkd.in/d-c4iSmn Here you will find: 👉 Current numbers in #biopharma sector: companies, employment, #funding & #financing, startups and clinical #drug pipeline 👉 Current sentiment on the #businessclimate and #AI of the biotech and pharmaceutical industry in Bavaria, Germany and Europe 👉 Interviews with Prof. Ralf Huss of BioM Biotech Cluster Development GmbH, Prof. Claudia Traidl-Hoffmann of Universität Augsburg/Helmholtz Munich and Prof. Matthias H. Tschöp of Helmholtz Munich/Technische Universität München 👉 Success Stories of #startups Tubulis GmbH and Ebenbuild 👉 Voices, advice and experiences on founding from the academy through the eyes of #founders, accelerators and #investors 👉 Driving Investments of Roche Deutschland, Minaris Regenerative Medicine, Daiichi Sankyo Europe GmbH und MSD with affirmation of #Bavaria as a global biotech hub 👉 Introducing BioM’s new incubator „Munich Accelerator Life Sciences & Medicine“ #MAxL, featuring #preseed teams RNATICS and Leopard Biosciences 👉 More insights on projects of the key players, stakeholders and #lifesciencehubs in Bavarian biotechnology from Invest in Bavaria - The Business Promotion Agency of the State of Bavaria, #DigiMedBayern, BioPark Regensburg GmbH, Innovations- und Gründerzentrum (IGZ) Würzburg, Medical Valley EMN e. V. and the IZB - Innovation and Start-up Center Biotechnology! 👉 > 300 #companyprofiles #Biotechreport #InnovationinBavaria #BavarianBiotechnologyCluster
-
🌟 Lesempfehlung - heute im Handelsblatt! Das litauische Start-up Biomatter Designs hat ein #KI-Modell für die Medikamentenwicklung erstellt, um dafür Enzyme zu analysieren, weiterzuentwickeln oder passgenau herzustellen. Dafür hat es nun 5,6 Millionen Euro eingesammelt. Für #BioM-Geschäftsführer Prof. Ralf Huss leistet Biomatter Designs Pioniertarbeit, denn: „Künstliche Intelligenz in der Biotechnologie ist derzeit noch ein schwer greifbares und sehr wissenschaftliches Thema. Da trauen sich viele Investoren nicht ran.“ Doch das Thema ist hochinteressant, weshalb auch Huss mit BioM in Bayern Start-ups in diesem Themenfeld aufbauen will. ➡ https://lnkd.in/diBmqVMZ Zu den Geldgebern gehören die Risikokapitalgesellschaften Inventure aus Helsinki und UVC Partners aus München, letztere vor allem durch die Beteiligungen an dem KI-Unternehmen Aleph Alpha sowie Flix und Lilium bekannt. Vielen Dank an Carolin Rainer vom Handelsblatt für das Interview! #biotech #digitalhealth #Bayern
-
🚀 Bereit für den nächsten Karrieresprung? 🚀 Wir suchen Verstärkung im Bereich Projektmanagement Innovation & Scouting! Was Dich erwartet: 💡 Du managst Projekte mit Fokus auf Unternehmensgründung und entdeckst neue Innovationen in Biotech und TechMed 💡 Du baust unser Ideen- und Projektscouting auf, besonders im frühen Gründungsstadium (Pre-Seed) 💡 Du betreust und unterstützt Teams und Projekte in der Vor- und Gründungsphase 💡 Du planst und setzt unsere Gründungskampagne (Bootcamp, Pitch-Training, Beratung) um – auch international, inklusive Reisetätigkeit 💡 Du unterstützt bei der Durchführung von Gründer- und Clusterevents 💡 Du arbeitest eng mit unserem Inkubations- und Start-up Team (MAxL) zusammen 💡 Du wirkst bei der Finanz-, Report- und Berichtserstellung mit 🌟 Interesse geweckt? Dann bewirb Dich jetzt und werde Teil unseres Teams! 🌟 Alle Infos zum Job unter: https://lnkd.in/d6deMqaR